Yong-Yu Liu Selected Research

Yong-Yu Liu Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 05/2004
13	Breast Neoplasms (Breast Cancer) 02/2019 - 05/2004
7	Colonic Neoplasms (Colon Cancer) 11/2020 - 05/2004
7	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2011
6	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 05/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 06/2012
4	Leukemia 01/2013 - 05/2004
4	Carcinogenesis 10/2012 - 01/2011
3	Lung Neoplasms (Lung Cancer) 12/2020 - 08/2015
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2012 - 01/2012
1	Hepatoblastoma 01/2022
1	Pathologic Processes 06/2019
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Wounds and Injuries (Trauma) 06/2018
1	Vomiting 01/2018
1	Neutropenia 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Ovarian Epithelial Carcinoma 08/2016
1	Hyperplasia 09/2015
1	Dyspnea (Shortness of Breath) 09/2015
1	Fistula 09/2015
1	Lymphatic Metastasis 12/2014
1	Carcinoma (Carcinomatosis) 12/2014
1	Prostatic Neoplasms (Prostate Cancer) 07/2014
1	Neoplasm Micrometastasis 07/2014

Drug/Important Bio-Agent (IBA)

17	CeramidesIBA 11/2020 - 05/2004
14	ceramide glucosyltransferaseIBA 09/2016 - 05/2004
12	Pharmaceutical PreparationsIBA 11/2020 - 05/2004
9	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2016 - 05/2004
7	EnzymesIBA 06/2019 - 05/2004
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2012
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2004
6	OligonucleotidesIBA 07/2012 - 05/2004
5	Gefitinib (Iressa)FDA Link 11/2021 - 01/2018
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2010 - 05/2004
4	Mutant Proteins (Protein, Mutant)IBA 01/2022 - 11/2014
4	SphingolipidsIBA 01/2020 - 09/2008
4	Biological ProductsIBA 11/2014 - 05/2004
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 02/2019
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 01/2018
3	GlycosphingolipidsIBA 11/2020 - 01/2011
3	CateninsIBA 11/2020 - 10/2012
3	RNA Precursors (Precursor, mRNA)IBA 01/2020 - 11/2014
3	N-caproylsphingosineIBA 01/2020 - 08/2010
3	Messenger RNA (mRNA)IBA 11/2014 - 07/2010
3	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 09/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2016
2	Glucosylceramides (Glucocerebrosides)IBA 06/2019 - 05/2004
2	Olive OilIBA 02/2019 - 01/2014
2	oleocanthalIBA 02/2019 - 01/2014
2	PeptidomimeticsIBA 09/2017 - 06/2015
2	Hematoxylin (Haematoxylon)IBA 09/2015 - 08/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 09/2015 - 08/2015
2	Lipid NanoparticlesIBA 07/2012 - 11/2010
2	CurcuminIBA 02/2012 - 01/2012
1	Cystine (L-Cystine)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	LigandsIBA 01/2022
1	LipidsIBA 01/2022
1	Complement System Proteins (Complement)IBA 12/2020
1	rubusosideIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 02/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2019
1	PaxillinIBA 02/2019
1	Lapatinib (GW572016)FDA Link 02/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	6-methyladenineIBA 01/2019
1	N-methyladenosineIBA 01/2019
1	Codon (Codons)IBA 01/2019
1	MethyltransferasesIBA 01/2019
1	CyclinsIBA 06/2018
1	goat lung surfactant extractIBA 06/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017
1	compound 18IBA 09/2017
1	RV 538 (PDMP)IBA 09/2016
1	Transcription Factors (Transcription Factor)IBA 09/2016
1	IG 10IBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 08/2016
1	AgarIBA 08/2016
1	Phenol (Carbolic Acid)FDA Link 09/2015
1	SuspensionsIBA 08/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015
1	EndostatinsIBA 08/2015
1	endostar proteinIBA 08/2015
1	AntibodiesIBA 06/2015
1	Phosphotransferases (Kinase)IBA 06/2015
1	Monoclonal AntibodiesIBA 06/2015
1	CarbonIBA 11/2014
1	fusarochromanoneIBA 09/2014
1	HydantoinsIBA 07/2014
1	Therapeutic UsesIBA 01/2014

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 11/2021 - 05/2004
12	Therapeutics 11/2021 - 05/2004
2	Radiotherapy 12/2014 - 07/2014
1	Traditional Medicine (Folk Remedies) 06/2018
1	Adjuvant Chemotherapy 01/2018
1	Intraperitoneal Injections 08/2015
1	Lymph Node Excision (Lymph Node Dissection) 12/2014